Theresa Winhusen1, Jeff Theobald2, David C Kaelber3, Daniel Lewis2. 1. Department of Psychiatry and Behavioral Neuroscience, University of Cincinnati College of Medicine, 3131 Harvey Avenue, Cincinnati, OH 45229, USA; Center for Addiction Research, University of Cincinnati College of Medicine, 3131 Harvey Avenue, Cincinnati, OH 45229, USA. Electronic address: winhust@uc.edu. 2. Department of Psychiatry and Behavioral Neuroscience, University of Cincinnati College of Medicine, 3131 Harvey Avenue, Cincinnati, OH 45229, USA; Center for Addiction Research, University of Cincinnati College of Medicine, 3131 Harvey Avenue, Cincinnati, OH 45229, USA. 3. Department of Information Services, The MetroHealth System, Cleveland, Ohio, USA; Departments of Internal Medicine, Pediatrics, and Population and Quantitative Health Sciences, Case Western Reserve University, Cleveland, Ohio, USA; The Center for Clinical Informatics Research and Education, The MetroHealth System, Cleveland, Ohio, USA.
Abstract
BACKGROUND: Understanding the potential impact of cocaine use on health is increasingly important as cocaine use rises in the U.S. OBJECTIVES: This study evaluated the associations of regular cocaine use, with and without tobacco co-use, with cardiovascular and respiratory outcomes. METHODS: Analysis of a limited dataset obtained through IBM Watson Health Explorys, a platform integrating electronic health record data. Matched controls were defined for: 1) cocaine-using patients (n = 8244; 44 % female); and subgroups of cocaine-using patients: 2) with an encounter diagnosis for tobacco use disorder (TUD; n = 4706); and 3) without a TUD diagnosis (non-TUD; n = 3538). Patients had at least one documented medical evaluation in the MetroHealth System (Cleveland, Ohio). Cocaine-using patients had an encounter diagnosis of cocaine abuse/dependence and/or ≥2 cocaine-positive drug screens. Control patients, with no documented cocaine-use, were matched to the cocaine-using patients on demographics, residential zip code median income, body mass index, and, for the total sample, TUD-status. Outcomes were encounter diagnosis (yes/no) of cerebrovascular accident, heart arrhythmia, myocardial infarction, subarachnoid hemorrhage, asthma, chronic obstructive pulmonary disease (COPD), pneumonia, and all-cause mortality. RESULTS: TUD-patients had the greatest prevalence of cardiovascular and respiratory disease, regardless of cocaine-use indication. In the total sample, TUD, and non-TUD subgroups, regular cocaine use was significantly associated with greater risk for cerebrovascular accident, arrhythmia, myocardial infarction, asthma, COPD, pneumonia and mortality. CONCLUSIONS: Cocaine use is associated with significantly greater risk of adverse cardiovascular and respiratory diagnoses and all-cause mortality.
BACKGROUND: Understanding the potential impact of cocaine use on health is increasingly important as cocaine use rises in the U.S. OBJECTIVES: This study evaluated the associations of regular cocaine use, with and without tobacco co-use, with cardiovascular and respiratory outcomes. METHODS: Analysis of a limited dataset obtained through IBM Watson Health Explorys, a platform integrating electronic health record data. Matched controls were defined for: 1) cocaine-using patients (n = 8244; 44 % female); and subgroups of cocaine-using patients: 2) with an encounter diagnosis for tobacco use disorder (TUD; n = 4706); and 3) without a TUD diagnosis (non-TUD; n = 3538). Patients had at least one documented medical evaluation in the MetroHealth System (Cleveland, Ohio). Cocaine-using patients had an encounter diagnosis of cocaine abuse/dependence and/or ≥2 cocaine-positive drug screens. Control patients, with no documented cocaine-use, were matched to the cocaine-using patients on demographics, residential zip code median income, body mass index, and, for the total sample, TUD-status. Outcomes were encounter diagnosis (yes/no) of cerebrovascular accident, heart arrhythmia, myocardial infarction, subarachnoid hemorrhage, asthma, chronic obstructive pulmonary disease (COPD), pneumonia, and all-cause mortality. RESULTS: TUD-patients had the greatest prevalence of cardiovascular and respiratory disease, regardless of cocaine-use indication. In the total sample, TUD, and non-TUD subgroups, regular cocaine use was significantly associated with greater risk for cerebrovascular accident, arrhythmia, myocardial infarction, asthma, COPD, pneumonia and mortality. CONCLUSIONS:Cocaine use is associated with significantly greater risk of adverse cardiovascular and respiratory diagnoses and all-cause mortality.
Authors: Marc G Romney; Mark W Hull; Réka Gustafson; Jat Sandhu; Sylvie Champagne; Titus Wong; Anouf Nematallah; Sara Forsting; Patricia Daly Journal: Clin Infect Dis Date: 2008-09-15 Impact factor: 9.079
Authors: W T Caiaffa; D Vlahov; N M Graham; J Astemborski; L Solomon; K E Nelson; A Muñoz Journal: Am J Respir Crit Care Med Date: 1994-12 Impact factor: 21.405
Authors: Hassan Burhan; Ryan Young; Tara Byrne; Robert Peat; Jennifer Furlong; Susan Renwick; Tristan Elkin; Sandra Oelbaum; Paul P Walker Journal: Chest Date: 2018-09-04 Impact factor: 9.410
Authors: Ahmed Brgdar; John Gharbin; Ayman Elawad; Jin Yi; Jacob Sanchez; Adey Bishaw; Mohamed E Taha; Edmund Essah Ameyaw; Norman Allen; Mehrotra Prafulla Journal: Cureus Date: 2022-03-01